IONS (Isis Pharmaceuticals) Earnings per share increase in current year
The financial stability of Ionis Pharmaceuticals (IONS) is supported by a significant liquidity reserve and the management of clinical phase risks. The annual EPS growth trajectory confirms the effectiveness of this strategy, and the value of -45.70 shows the most recent earnings per share. Revenues are based on research contracts and royalties, while strategic alliances with pharma behemoths accelerate the market launch of therapies for rare pathologies.
Financial and market metric breakdowns for Ionis Pharmaceuticals (IONS)
- current price and projected stock value:
- business market valuation indicators:
- business book valuation details:
- debt burden and liquidity indicators:
- earnings and market multiples details:
IONS - Net Income|Future Net Profit Ionis Pharmaceuticals|IONS - P/E Multiple|Market Cap to Projected Earnings Isis Pharmaceuticals|IONS - PEG Multiple|Enterprise Value to EBITDA Ratio Isis Pharmaceuticals|IONS - Operating profit EBITDA|Net earnings per share (EPS TTM) Ionis|IONS - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months ionispharma.com|IONS - Earnings per share growth in current year|Consensus forecast of earnings per share growth for next year Ionis Pharmaceuticals
- revenue and sales proceeds data:
Fundamental valuation:IONS, Ionis Pharmaceuticals, Inc.
To objectively evaluate Ionis Pharmaceuticals (IONS), it is critical to filter out market noise and analyze real yield dynamics. By analyzing the annual volatility of earnings per share, an investor can see the percentage ratio of current EPS to the previous year, revealing true capital stability beyond speculation. For a developer of RNA therapeutics with a low environmental footprint, such a metric confirms the efficiency of capitalizing pure laboratory research into real financial growth.
Direct competitors
Earnings per share trend in current year TEM (Tempus Labs)|QGEN (Qiagen Group) - Earnings growth in current year|RGEN: Earnings per share increase in current year|Earnings growth in current year RNA|Earnings growth in current year crisprtx.com (CRSP)|Earnings per share growth in current year GeneDx WGS|Earnings per share increase in current year RARE|BEAM - Earnings per share growth in current year|Sarepta Corp (SRPT) - Net earnings per share growth this year|TWST: Earnings growth in current year|10xgenomics.com (TXG) - Earnings growth in current year|NTLA (Intellia Therapeutics, Inc.) - Earnings growth in current year|Net earnings per share growth this year Stoke Therapeutics Inc (STOK)|Earnings growth in current year BLFS|WVE - Earnings per share growth rate in current year|Maze Therapeutics Inc - Net earnings per share growth this year|Earnings growth in current year sionnatx.com SION|PRME: Net earnings per share growth this year|Taysha Gene Therapies Inc - Net earnings per one share growth for the current year|QURE: Earnings growth in current year|MGTX - Expected net earnings per share growth this year|RGNX (REGENXBIO Inc.) - Earnings growth in current year|Net earnings per share growth this year solidbio.com (SLDB)|Earnings growth in current year OCGN|Earnings growth in current year Pacific Biosciences of California, Inc. (PACB)|Earnings per share growth in current year Benitec BNTC|Design Corp - Earnings per share growth in current year|RCKT - Earnings per share growth in current year|Expected net earnings per share growth this year 4dmoleculartherapeutics.com FDMT|LXEO: Earnings growth in current year|KRRO - Expected net earnings per share growth this year|Earnings per share growth in current year Editas|Earnings per share growth rate in current year Silence Therapeutics Corp SLN|Earnings per share growth in current year ProQR Therapeutics N.V. (PRQR)|codexis.com - Earnings per share growth this year|Earnings per share growth in current year Sangamo Therapeutics, Inc. SGMO|Expected net earnings per share growth this year Nautilus Biotechnology, Inc. (NAUT)|Metagenomi, Inc - Earnings growth in current year|DTIL (precisionbiosciences.com) - Earnings per share growth this year|generationbio.com (GBIO) - Earnings per share growth in current year|Earnings per share growth this year BOLD|XCUR (Exicure Inc.) - Earnings growth in current year|Earnings growth in current year Celsion Corporation|Earnings growth in current year PHIO|Expected net earnings per share growth this year mustangbio.com|Earnings per share growth in current year TransCode Therapeutics, Inc. RNAZ|Bionano Genomics Inc. (BNGO) - Earnings per share growth rate in current year|APDN - Earnings per share growth in current year|BLUE (bluebird bio Inc.) - Earnings per share growth this year|IPA: Earnings growth in current year|OMGA - Expected net earnings per share growth this year|Earnings per share growth in current year Singular Genomics Systems|regulusrx.com (RGLS) - Expected net earnings per share growth this year|Net earnings per share growth this year SYRS (Syros Pharmaceuticals, Inc.)|TBIO (Telesis Bio Inc.) - Earnings per share increase in current year|Earnings per share growth in current year TRACON TCON|UBX (Unity Biotechnology, Inc) - Earnings per share trend in current year
